BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Ebola outbreak
Hantavirus
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Saturday, June 6, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
May 16, 2008
View Archived Issues
Novel antiinflammatory agents disclosed in recent patents
Read More
Health Canada approves PolyMedix's CTA for phase I clinical study of PMX-30063
Read More
Medtronic initiates phase III trial comparing Endeavor with Xience coronary stents
Read More
Alseres announces 12-month interim data from phase I/IIa clinical trial of Cethrin in SCI
Read More
Nventa reports positive results from third cohort in phase I clinical trial of HspE7 for CIN
Read More
arGentis licenses ARG-103 for dry eye syndrome from Southern College of Optometry
Read More
Ranbaxy and Merck & Co. sign collaboration agreement for antiinfective drug candidates
Read More
Health Canada grants approval to Thallion to initiate phase II clinical trial of TLN-4601
Read More
Placental growth factor blockade useful in mouse models of CNV
Read More
Novel VEGFR-2 inhibitor profiled at Bristol-Myers Squibb
Read More
New therapeutic agents for cancer reported in recent patent literature
Read More
Bristol-Myers and KAI enter license agreement for KAI-9803 in cardiovascular disease
Read More
Valeant reports positive results from phase III RESTORE 2 trial of retigabine in epilepsy
Read More
ImClone initiates enrollment in phase II clinical trial of IMC-A12 in liver cancer
Read More
Synvista initiates dosing in a phase II study of alagebrium in diastolic heart failure
Read More
Oncolytics receives U.K. approval to initiate phase II clinical trial of Reolysin in cancer
Read More
AEterna Zentaris initiates dosing in phase III safety trial of cetrorelix in BPH
Read More
Ardana reports preliminary results from phase III study of testosterone cream in hypogonadal men
Read More
Chugai and Taisho sign agreement to codevelop and comarket eldecalcitol for osteoporosis
Read More
Newron acquires Hunter-Fleming
Read More
Pfizers's ziprasidone under study in children and adolescents with bipolar I disorder
Read More
Novel DNA vaccine encoding calreticulin shows protection against anthrax toxin in vivo
Read More
Allos Therapeutics reports interim response and safety data from phase II trial
Read More
Orexo submits NDA to the FDA for Sublinox (OX-22) for short-term insomnia
Read More
Positive preclinical and clinical results of ViroChem's novel HCV polymerase inhibitor
Read More
Wyeth's Pristiq available in U.S. pharmacies for major depressive disorder
Read More
